Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
GenBioPro Sues FDA To Keep Generic Mifepristone Available; Supreme Court Delays Its Decision
Apr 20 2023
•
By
Brenda Sandburg
GenBioPro asks court to prevent FDA from taking enforcement action against its generic mifepristone • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership